ZachXBT Alleges LAB Insiders Control 95% of Token Supply
On-chain investigator ZachXBT published allegations that LAB insiders likely control over 95% of the token's circulating supply following a rally that valued the project at roughly $6 billion. The claims center on opaque private loans, OTC transactions, and vesting-schedule changes.
Key Takeaways
- 1## Investigator's Allegations ZachXBT, a prominent on-chain analyst, published a detailed thread alleging that LAB insiders have retained control of more than 95% of the token's supply despite the project's $6 billion fully diluted valuation.
- 2His investigation cites a pattern of opaque private loans, off-the-books OTC deals, and unilateral modifications to vesting terms as evidence that retail buyers have limited actual ownership.
- 3## Claimed Mechanisms ZachXBT pointed to market-maker coordination and what he described as undisclosed insider arrangements as key mechanisms enabling the concentration.
- 4The allegations suggest vesting schedules were altered in ways that were not publicly communicated, and that private lending arrangements allowed insiders to maintain leverage while appearing to have reduced holdings.
- 5## Why It Matters ### For Traders If allegations of 95% insider control hold up, LAB faces significant sell-pressure risk when vesting milestones arrive or insiders liquidate positions.
Investigator's Allegations
ZachXBT, a prominent on-chain analyst, published a detailed thread alleging that LAB insiders have retained control of more than 95% of the token's supply despite the project's $6 billion fully diluted valuation. His investigation cites a pattern of opaque private loans, off-the-books OTC deals, and unilateral modifications to vesting terms as evidence that retail buyers have limited actual ownership.
Claimed Mechanisms
ZachXBT pointed to market-maker coordination and what he described as undisclosed insider arrangements as key mechanisms enabling the concentration. The allegations suggest vesting schedules were altered in ways that were not publicly communicated, and that private lending arrangements allowed insiders to maintain leverage while appearing to have reduced holdings.
Why It Matters
For Traders
If allegations of 95% insider control hold up, LAB faces significant sell-pressure risk when vesting milestones arrive or insiders liquidate positions.
For Investors
The pattern described — opaque allocation, vesting changes, OTC deals — mirrors structures flagged in past exit scams; due diligence on founder and core-team lockups is critical.
For Builders
Projects launching tokens should establish transparent vesting schedules on-chain and publish allocation breakdowns before launch to avoid similar accusations.
